Skip to main navigation Skip to search Skip to main content

Changes in sphingolipid levels induced by epidermal growth factor in osteoblastic cells. Effects of these metabolites on cytosolic calcium levels

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Sphingolipids mediate a number of cellular functions in a variety of cell systems. The role they play in osteoblast signaling is yet unknown. This study investigated the effects of epidermal growth factor (EGF) on the levels of ceramide, sphingosine (SPH), and sphingosine-1-phosphate (S1P) in rat calvariae osteoblastic cells, and whether these metabolites mediated cytosolic calcium ([Ca2+](i)) mobilization in these cells. EGF significantly (P<0.05) increased the levels of all three sphingolipids, and the phorbol ester PMA partially inhibited these effects. SPH and S1P markedly increased [Ca2+](i) levels, with thapsigargin (depletes [Ca2+](i) pools) decreasing the response by 60%. Verapamil (calcium channel blocker) only inhibited ceramide's effects on [Ca2+](i). Furthermore, SPH enhanced the EGF' induced increase in [Ca2+](i). This study demonstrates that ceramide, SPH and S1P mediate [Ca2+](i) mobilization in rat calvarial osteoblastic cells, and that EGF induces changes in the levels of these metabolites with PKC playing an important role in the mechanisms regulating these events. (C) 2000 Harcourt Publishers Ltd.

Original languageEnglish
Pages (from-to)225-232
Number of pages8
JournalProstaglandins Leukotrienes and Essential Fatty Acids
Volume62
Issue number4
DOIs
StatePublished - Apr 2000

Fingerprint

Dive into the research topics of 'Changes in sphingolipid levels induced by epidermal growth factor in osteoblastic cells. Effects of these metabolites on cytosolic calcium levels'. Together they form a unique fingerprint.

Cite this